Identifying tumor antigens and immuno‐subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccine

The mRNA vaccine has provided a promising approach for cancer immunotherapies. However, only a few mRNA vaccines have been developed against colon adenocarcinoma (COAD). Screening potential targets for mRNA vaccines from numerous candidates is a substantial challenge. Considering the tumor heterogen...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Huaicheng, Yu, Ting, Liu, Chunhua, Wang, Yang, Jing, Fangqi, Ding, Zhenyu, Liu, Jiyan, Shi, Huashan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741973/
https://www.ncbi.nlm.nih.gov/pubmed/35593226
http://dx.doi.org/10.1002/cam4.4846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9741973/
https://www.ncbi.nlm.nih.gov/pubmed/35593226
http://dx.doi.org/10.1002/cam4.4846

Ejemplares similares